Deng Ye, Balunas Marcy J, Kim Jeong-Ah, Lantvit Daniel D, Chin Young-Won, Chai Heebyung, Sugiarso Sugeng, Kardono Leonardus B S, Fong Harry H S, Pezzuto John M, Swanson Steven M, de Blanco Esperanza J Carcache, Kinghorn A Douglas
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA.
J Nat Prod. 2009 Jun;72(6):1165-9. doi: 10.1021/np9001724.
Six new 5,6-dihydro-alpha-pyrone derivatives (1-6), namely, brevipolides A-F, together with seven known compounds, including a 5,6-dihydro-alpha-pyrone derivative (7), three flavonoids, a steroid glycoside, and two triterpenoids, were isolated from the entire plant of Hyptis brevipes. Compounds 1-7 were assigned with the absolute configuration 5R, 6S, 7S, and 9S, as elucidated by analysis of data obtained from their CD spectra and by Mosher ester reactions. Compounds 2, 6, and 7 exhibited ED(50) values of 6.1, 6.7, and 3.6 microM against MCF-7 cells, and compounds 1, 2, 6, and 8 (the known 5,6,3'-trihydroxy-3,7,4'-trimethoxyflavone) gave ED(50) values of 5.8, 6.1, 7.5, and 3.6 microM against HT-29 cells, respectively. However, no significant cytotoxicity was found against Lu1 cells for any of the compounds isolated. When these compounds were subjected to evaluation in a panel of mechanism-based in vitro assays, compound 7 was found to be active in an enzyme-based ELISA NF-kappaB assay, with an ED(50) value of 15.3 microM. In a mitochondrial transmembrane potential assay, compounds 3, 7, and 8 showed ED(50) values of 8.5, 75, and 310 nM, respectively. No potent activity was found in a proteasome inhibition assay for any of the isolated compounds.
从短柄山香(Hyptis brevipes)全草中分离得到6个新的5,6-二氢-α-吡喃酮衍生物(1-6),即短柄山香内酯A-F,以及7个已知化合物,包括1个5,6-二氢-α-吡喃酮衍生物(7)、3个黄酮类化合物、1个甾体糖苷和2个三萜类化合物。通过对其圆二色谱数据和Mosher酯反应分析,确定化合物1-7的绝对构型为5R、6S、7S和9S。化合物2、6和7对MCF-7细胞的半数有效剂量(ED50)值分别为6.1、6.7和3.6 μM,化合物1、2、6和8(已知的5,6,3'-三羟基-3,7,4'-三甲氧基黄酮)对HT-29细胞的ED50值分别为5.8、6.1、7.5和3.6 μM。然而,所分离的任何化合物对Lu1细胞均未发现明显的细胞毒性。当这些化合物在一组基于机制的体外试验中进行评估时,发现化合物7在基于酶联免疫吸附测定(ELISA)的NF-κB试验中具有活性,ED50值为15.3 μM。在线粒体跨膜电位试验中,化合物3、7和8的ED50值分别为8.5、75和310 nM。在所分离的任何化合物的蛋白酶体抑制试验中均未发现强效活性。